Mianserine Cristers (Mianserin Hydrochloride)

Mianserin is a tetracyclic antidepressant used primarily in the management of depressive disorders.

• Major depressive disorder: reduces depressive symptoms and improves mood in adult patients.
• Treatment‑resistant depression: may be added when first‑line agents are insufficient.
• Depressive episodes in bipolar disorder (as adjunct): helps control depressive phases when used under specialist supervision.

• Mianserin acts as an antagonist at central presynaptic alpha‑2 adrenergic receptors, increasing norepinephrine release, while also blocking histamine H1 receptors and several serotonin receptors (5‑HT2 and 5‑HT3). This combined activity enhances monoaminergic neurotransmission and produces antidepressant effects without direct serotonin reuptake inhibition.

Mianserin may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Weight gain: increase in body weight over time.
• Dry mouth: reduced salivation leading to oral discomfort.
• Constipation: infrequent or difficult bowel movements.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Increased appetite: heightened desire for food.

Serious or Rare Side Effects

• Agranulocytosis: severe reduction in white blood cells.
• Seizures: convulsive episodes, especially at high doses.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening.
• Suicidal thoughts: emergence or worsening of suicidal ideation.
• Liver injury: signs of hepatic dysfunction such as jaundice.

Before initiating therapy with Mianserin, several safety considerations are recommended.

• Monitor blood pressure: watch for orthostatic hypotension, especially at treatment start.
• Assess suicidal risk: evaluate mood and thoughts regularly, particularly in early weeks.
• Evaluate hepatic function: check liver enzymes before and during treatment.
• Use caution in the elderly: increased sensitivity to sedation and anticholinergic effects.
• Avoid abrupt discontinuation: taper dose to reduce withdrawal symptoms.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mianserin can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and serotonin syndrome.
• Selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents: increased serotonin syndrome risk.
• CNS depressants (e.g., benzodiazepines, barbiturates): additive sedation and respiratory depression.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise Mianserin plasma levels.
• Antihypertensive drugs: potential additive blood‑pressure lowering effect.
• Alcohol: enhances central nervous system depression.
• Anticholinergic medications: may worsen dry mouth and constipation.
• Other antidepressants (e.g., tricyclics): monitor for overlapping side‑effects.